Market Value1,174,519,254
Total Holdings60
File Date2025-02-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
BCAB / BioAtla, Inc.
QURE / uniQure N.V.
RLAY / Relay Therapeutics, Inc.
RNA / Atrium Therapeutics, Inc.
GERN / Geron Corporation
PSTX / Poseida Therapeutics, Inc.
TERN / Terns Pharmaceuticals, Inc.
MRSN / Mersana Therapeutics, Inc.
SRRK / Scholar Rock Holding Corporation
MIST / Milestone Pharmaceuticals Inc.
OLMA / Olema Pharmaceuticals, Inc.
AMLX / Amylyx Pharmaceuticals, Inc.
PRTA / Prothena Corporation plc
SANA / Sana Biotechnology, Inc.
MRUS / Merus N.V.
KALV / KalVista Pharmaceuticals, Inc.
APLS / Apellis Pharmaceuticals, Inc.
SWTX / SpringWorks Therapeutics, Inc.
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
CGEM / Cullinan Therapeutics, Inc.
KROS / Keros Therapeutics, Inc.
DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
ORIC / ORIC Pharmaceuticals, Inc.
SYRE / Spyre Therapeutics, Inc.
OBIO / Orchestra BioMed Holdings, Inc.
LEGN / Legend Biotech Corporation - Depositary Receipt (Common Stock)
RCKT / Rocket Pharmaceuticals, Inc.
THRD / Third Harmonic Bio, Inc.
IOVA / Iovance Biotherapeutics, Inc.
BOLD / Boundless Bio, Inc.
ANAB / AnaptysBio, Inc.
ELVN / Enliven Therapeutics, Inc.
JSPR / Jasper Therapeutics, Inc.
CLYM / Climb Bio, Inc.
PRLD / Prelude Therapeutics Incorporated
RCUS / Arcus Biosciences, Inc.
DAWN / Day One Biopharmaceuticals, Inc.
XENE / Xenon Pharmaceuticals Inc.
ITOS / iTeos Therapeutics, Inc.
NUVB.WS / Panacea Acquisition Corp. - Equity Warrant
NRIX / Nurix Therapeutics, Inc.
REPL / Replimune Group, Inc.
TIL / Instil Bio, Inc.
SRZNW / Surrozen, Inc. - Equity Warrant
RVMD / Revolution Medicines, Inc.
KYMR / Kymera Therapeutics, Inc.
CMRX / Chimerix, Inc.
ARVN / Arvinas, Inc.
TYRA / Tyra Biosciences, Inc.
BDTX / Black Diamond Therapeutics, Inc.
KOD / Kodiak Sciences Inc.
NUVL / Nuvalent, Inc.
TNGX / Tango Therapeutics, Inc.
SMMT / Summit Therapeutics Inc.
APGE / Apogee Therapeutics, Inc.
BCAX / Bicara Therapeutics Inc.
ZURA / Zura Bio Limited
ZNTL / Zentalis Pharmaceuticals, Inc.
IMVT / Immunovant, Inc.
AXSM / Axsome Therapeutics, Inc.